Dr Sanjit Jolly (McMaster University, Hamilton, ON) discusses FUTURA OASIS 8: a randomized trial comparing two regimens of adjunctive intravenous unfractionated heparin during PCI in high-risk patients with non-STE-ACS treated with fondaparinux.
Recorded at the ESC convention center in Stockholm, Sweden on Tuesday, August 31.